Spiriva HandiHaler (Tiotropium)

News
Article

Anticholinergic approved for COPD

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Peter Togel-stock@adobe.com

Teva Launches First Generic GLP-1 Drug for Obesity

Formulary Watch
August 29th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
August 29th 2025
Podcast

Listen

olgakris-stock@adobe.com

Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial

Denise Myshko
August 29th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 29th 2025
Podcast

Listen

FDA Approves First in Class Therapy for Hereditary Angioedema

FDA Approves First in Class Therapy for Hereditary Angioedema

Denise Myshko
August 29th 2025
Article

Read More

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar

MedImpact To Offer Unbranded Ustekinumab-aekn Biosimilar

Logan Lutton
August 29th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.